Log In
BCIQ
Print this Print this
 

Portaban, oral ifetroban

  Manage Alerts
Collapse Summary General Information
Company Cumberland Pharmaceuticals Inc.
DescriptionOral thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor antagonist
Molecular Target Thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Hepatic (unspecified)
Indication DetailsTreat portal hypertension in patients with liver cirrhosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today